This is a three-year research study for people with primary membranous nephropathy (primary MN). The study will test if combining belimumab and rituximab is effective in treating Primary MN.
At each visit, you will meet with a member of the study team and answer questions about your health and your medications. We will take your vitals. Some visits will include the rituximab infusion, the belimumab or placebo being injected under your skin, a 24 hour urine collection, some questionnaires..
$50 per visit
Clinical or Medical
Kidneys and Liver